ClinicalTrials.Veeva

Menu

Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions Characterization

G

Graziella di Grezia

Status

Invitation-only

Conditions

Breast Cancer Detection
Breast Cancer Diagnosis

Treatments

Diagnostic Test: CEM protocol

Study type

Observational

Funder types

Other

Identifiers

NCT06846814
T_4_2025

Details and patient eligibility

About

This study investigates the utility of second-look ultrasound (US) following contrast-enhanced mammography (CEM) to characterize additional lesions detected during routine breast imaging.

Full description

The goal is to assess the diagnostic accuracy and clinical value of combining CEM with targeted ultrasound to improve lesion characterization and guide biopsy decisions.

Enrollment

350 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing contrast-enhanced mammography for diagnostic or surveillance purposes.
  • Identification of additional lesions on CEM requiring further evaluation.
  • Ability to provide informed consent.

Exclusion criteria

  • Known breast cancer diagnosis without suspicion of additional lesions.
  • Contraindications to ultrasound or contrast agents.
  • Patients with incomplete imaging data.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems